# US 2025/0152528 A1 · Rapid relief spray

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0152528 A1
- Document ID: US20250152528A1
- Status: Published application
- Kind: A1
- Application number: 18/835,393
- Filed: 2022-02-10
- Published: 2025-05-15
- Earliest claimed: 2022-02-10
- Assignees: Haleon US Holdings LLC
- Applicants: Haleon US Holdings LLC
- Inventors: Shivangi Akash PATEL; Christopher Michael OHLHAVER; Fitsum Feleke SAHLE
- Web page: https://patentgrep.com/patent/US20250152528A1

## CPC

- A61K 31/167: having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A61K 9/0031: {Rectum, anus}
- A61K 9/08: Solutions {(composition of solutions A61K47/00)}
- A61K 31/137: Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine {or methadone}
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/12: Carboxylic acids; Salts or anhydrides thereof
- A61K 47/14: Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

An aqueous composition comprising lidocaine and at least two weak acids, each having at least one carboxylic acid group with a pKa of 2 to 5, wherein the aqueous composition has a pH of 3.5 to 4.1. The aqueous composition can further comprise phenylephrine HCl.

## Claims

### Claim 1

An aqueous composition comprising:
lidocaine; and
at least two weak acids, each having at least one carboxylic acid group with a pKa of 2 to 5,
wherein the aqueous composition has a pH of 3.5 to 4.1.

### Claim 2 (depends on 1)

The aqueous composition of claim 1, comprising 2 to 5 wt. % lidocaine.

### Claim 3 (depends on 1)

The aqueous composition of claim 1, further comprising phenylephrine HCl.

### Claim 4 (depends on 3)

The aqueous composition of claim 3, comprising 0.25 wt. % phenylephrine HCl.

### Claim 5 (depends on 1)

The aqueous composition of claim 1, wherein each of the at least two weak acids is citric acid, malic acid, acetic acid, tartaric acid, or ascorbic acid.

### Claim 6 (depends on 1)

The aqueous composition of claim 1, wherein one of the at least two weak acids is citric acid.

### Claim 7 (depends on 6)

The aqueous composition of claim 6, wherein the other of the at least two weak acids is malic acid, acetic acid, tartaric acid, or ascorbic acid.

### Claim 8 (depends on 1)

The aqueous composition of claim 1, wherein one of the at least two weak acids is malic acid.

### Claim 9 (depends on 8)

The aqueous composition of claim 8, wherein the other of the at least two weak acids is citric acid, acetic acid, tartaric acid, or ascorbic acid.

### Claim 10 (depends on 1)

The aqueous composition of claim 1, wherein the at least two weak acids are citric acid and malic acid.

### Claim 11 (depends on 1)

The aqueous composition of claim 1, wherein the at least two weak acids are present in a ratio of 5:3 to 1:3 based on wt. %.

### Claim 12 (depends on 10)

The aqueous composition of claim 10 comprising 3.6 wt. % citric acid and 1 wt. % malic acid.

### Claim 13 (depends on 1)

The aqueous composition of claim 1, further comprising one or more of an antioxidant, a chelating agent, an emollient, a humectant, a preservative, a cooling agent, and a propellant.

### Claim 14 (depends on 13)

The aqueous composition of claim 13, wherein the antioxidant comprises propyl gallate, ascorbic acid, sodium metabisulfite, potassium metabisulfite, alpha tocopherol, or any combination thereof.

### Claim 15 (depends on 13)

The aqueous composition of claim 13, wherein the antioxidant comprises 0.01 to 0.1 wt. % propyl gallate.

### Claim 16 (depends on 13)

The aqueous composition of claim 13, wherein the chelating agent comprises disodium ethylenediaminetetraacetic acid (“EDTA”), edetic acid, or a combination of both.

### Claim 17 (depends on 13)

The aqueous composition of claim 13, wherein the emollient comprises one or more of Aloe Barbadensis leaf juice, shea butter, vitamin E or pharmaceutically acceptable salts thereof, or any combination thereof.

### Claim 18 (depends on 13)

The aqueous composition of claim 13, wherein the humectant comprises one or more of propylene glycol, glycerin, or any combination thereof.

### Claim 19 (depends on 13)

The aqueous composition of claim 13, wherein the preservative comprises one or more of sodium benzoate, benzyl alcohol, methyl paraben, propyl paraben, or any combination thereof.

### Claim 20 (depends on 13)

The aqueous composition of claim 13, wherein the cooling agent comprises menthol.

### Claim 21 (depends on 1)

The aqueous composition of claim 1, further comprising ethanol, isopropanol, or a combination thereof.

### Claim 22 (depends on 1)

The aqueous composition of claim 1, further comprising a propellant, the propellant comprising isobutane, propane, N-butane, or any combination thereof.

### Claim 23

An aqueous composition comprising:
lidocaine;
phenylephrine HCl;
citric acid; and
malic acid,
wherein the aqueous composition has a pH of 3.5 to 4.1.

### Claim 24 (depends on 23)

The aqueous composition of claim 23 comprising 2 to 5 wt. % lidocaine.

### Claim 25 (depends on 23)

The aqueous composition of claim 23 comprising 0.25 wt. % phenylephrine HCl.

### Claim 26 (depends on 23)

The aqueous composition of claim 23 comprising 3.6 wt. % citric acid.

### Claim 27 (depends on 23)

The aqueous composition of claim 23 comprising 1 to 5 wt. % malic acid.

### Claim 28 (depends on 23)

The aqueous composition of claim 23, further comprising 10 to 20 wt. % glycerin.

### Claim 29 (depends on 23)

The aqueous composition of claim 23, further comprising 0.01 to 0.1 wt. % propyl gallate.

### Claim 30 (depends on 23)

The aqueous composition of claim 23, further comprising 0.001 to 0.08 wt. % menthol.

### Claim 31 (depends on 23)

The aqueous composition of claim 23, further comprising 5 to 10 wt. % ethanol.

### Claim 32 (depends on 1)

A method of treating pain or inflammation in a mammalian subject comprising topically administering a therapeutically effective amount of the composition according to claim 1 to a mammalian subject in need thereof.

### Claim 33 (depends on 1)

A spray device comprising the composition according to claim 1.

### Claim 34

An aqueous composition comprising:
lidocaine;
phenylephrine HCl; and
at least two weak acids selected from a group consisting essentially of citric acid, malic acid, acetic acid, tartaric acid, and ascorbic acid,
wherein the aqueous composition has a pH of 3.5 to 4.1.

### Claim 35

An aqueous composition comprising:
lidocaine;
phenylephrine HCl; and
citric acid in combination with at least one weak acid having at least one carboxylic acid group with a pKa of 2 to 5,
wherein the aqueous composition has a pH of 3.5 to 4.1.

### Claim 36 (depends on 34)

The aqueous composition of claim 34, comprising 2 to 5 wt. % lidocaine.

### Claim 37 (depends on 34)

The aqueous composition of claim 34, comprising 0.25 wt. % phenylephrine HCl.
